Hydrocodone Bitartrate And Acetaminophen Tablet
FDA Label NDC 63629-5422

48 label sections · Submitted to the FDA by Bryant Ranch Prepack · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Hydrocodone Bitartrate And Acetaminophen (NDC 63629-5422). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: addiction, abuse, and misuse; risk evaluation and mitigation strategy (rems); life-threatening respiratory depression; accidental ingestion; neonatal opioid withdrawal syndrome; cytochrome p450 3a4 interaction; hepatotoxicity; and risks from concomitant use with benzodiazepines or other cns depressants, description, clinical pharmacology, indications and usage, contraindications, addiction, abuse, and misuse, opioid analgesic risk evaluation and mitigation strategy (rems), life-threatening respiratory depression, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

Hydrocodone Bitartrate and Acetaminophen Tablets 5mg/325mg (CII)

Label (Lbl636295422)

Label (Lbl636295422)

* Please review the disclaimer below.